VISTAGEN THERAPEUTICS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
VISTAGEN THERAPEUTICS, INC. (VTGN) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $60.00 thousand as of 2026-03-31, per its 10-K filed 2026-06-15.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-06-15
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $60.00K.
- 2025-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $170.00K.
- 2024-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $329.00K.
- 2023-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $478.10K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-03-31 | $60.00K 10-K · filed 2026-06-15 |
| 2025-03-31 | $170.00K 10-K · filed 2025-06-17 |
| 2024-03-31 | $329.00K 10-K · filed 2024-06-11 |
| 2023-06-30 | $478.10K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $532.90K 10-K · filed 2023-06-28 |
| 2022-12-31 | $590.10K 10-Q · filed 2023-02-07 |
| 2022-09-30 | $649.60K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $711.50K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $775.60K 10-K · filed 2022-06-23 |
| 2021-12-31 | $841.90K 10-Q · filed 2022-02-10 |
| 2021-09-30 | $1.01M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.09M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.17M 10-K · filed 2021-06-29 |
| 2020-12-31 | $1.25M 10-Q · filed 2021-02-11 |
| 2020-09-30 | $1.33M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.41M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $1.50M 10-K · filed 2020-06-29 |
| 2019-12-31 | $1.58M 10-Q · filed 2020-02-13 |
| 2019-09-30 | $1.67M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.76M 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |